TTOO

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

T2 Biosystems Inc

PINK | TTOO

0.00

USD

$0.00

(

0.00%

)

At Close (As of Oct 13, 2025)

$196.32K

Market Cap

-

P/E Ratio

-0.03

EPS

$1.86

52 Week High

$0.00

52 Week Low

HEALTHCARE

Sector

TTOO Chart

Recent Chart
Price Action

TTOO Technicals

Tags:

TTOO Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$8.2M
Total Revenue $7.2M
Cost Of Revenue $15M
Costof Goods And Services Sold $15M
Operating Income -$50M
Selling General And Administrative $26M
Research And Development $14M
Operating Expenses $41M
Investment Income Net -
Net Interest Income -$5.7M
Interest Income -
Interest Expense $5.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $859K
Income Before Tax -$50M
Income Tax Expense $691K
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$45M
Ebitda -$44M
Net Income -$50M

Revenue & Profitability

Earnings Performance

TTOO Financials

yearly Balance Sheet (As of Dec 31, 2023)

Field Value (USD)
Total Assets $35M
Total Current Assets $25M
Cash And Cash Equivalents At Carrying Value $16M
Cash And Short Term Investments $16M
Inventory $4.8M
Current Net Receivables $1.4M
Total Non Current Assets $9.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $3.3M
Other Non Current Assets -
Total Liabilities $63M
Total Current Liabilities $56M
Current Accounts Payable $1.5M
Deferred Revenue -
Current Debt -
Short Term Debt $43M
Total Non Current Liabilities $6.7M
Capital Lease Obligations $8.2M
Long Term Debt -
Current Long Term Debt $41M
Long Term Debt Noncurrent -
Short Long Term Debt Total $49M
Other Current Liabilities $12M
Other Non Current Liabilities -
Total Shareholder Equity -$28M
Treasury Stock -
Retained Earnings -$584M
Common Stock $4K
Common Stock Shares Outstanding $2.6M

yearly Cash Flow (As of Dec 31, 2023)

Field Value (USD)
Operating Cashflow -$48M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $859K
Capital Expenditures $192K
Change In Receivables -
Change In Inventory -$744K
Profit Loss -
Cashflow From Investment -$192K
Cashflow From Financing $53M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$50M

yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$8.2M
Total Revenue $7.2M
Cost Of Revenue $15M
Costof Goods And Services Sold $15M
Operating Income -$50M
Selling General And Administrative $26M
Research And Development $14M
Operating Expenses $41M
Investment Income Net -
Net Interest Income -$5.7M
Interest Income -
Interest Expense $5.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $859K
Income Before Tax -$50M
Income Tax Expense $691K
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$45M
Ebitda -$44M
Net Income -$50M

TTOO Profile

T2 Biosystems Inc Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

T2 Biosystems, Inc. is an innovative in vitro diagnostic company based in Lexington, Massachusetts, focused on developing cutting-edge diagnostic products for rapid and accurate detection of pathogens in the healthcare sector. By harnessing proprietary technology, T2 Biosystems enhances clinical decision-making and improves patient outcomes through timely diagnostics. The company operates both domestically and internationally, positioning itself as a leader in the diagnostic space, particularly amid growing demand for efficient pathogen detection solutions.

VHAI
+66.66%
$0.00
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
GWH
+117.54%
$9.05
IONZ
-32.55%
$2.29
GPUS
-10.39%
$0.43
SSKN
+42.92%
$2.20
F
+1.13%
$11.54
BURU
-16.87%
$0.42
AXDX
-61.36%
$0.03
ITP
+13.42%
$0.29
YYAI
-22.88%
$0.13
SOUN
+10.25%
$19.14
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IONQ
+16.19%
$82.09
BITF
-4.45%
$5.15
UAMY
+36.85%
$16.71
ABAT
+36.59%
$9.22
KDLY
-1.56%
$0.85
RGTI
-4.27%
$52.55
NVTS
+16.85%
$11.65
EOSE
+23.37%
$17.05
UGRO
+34.02%
$0.49
EDHL
+74.38%
$0.87
RMBL
+60.50%
$3.21
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
XCH
+103.41%
$1.68
CLSK
+3.94%
$20.04
SRM
+53.27%
$10.30
MNTS
+17.83%
$1.68
GDXD
-13.62%
$0.73
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
SLB
+1.73%
$32.27
WLGS
-5.57%
$0.04
BYND
-16.89%
$0.86
ETWO
0.00%
$3.30
AFMD
-34.94%
$0.18
IXHL
+4.29%
$0.40
TMQ
+16.92%
$7.67
NVDA
-4.29%
$180.22
MU
+6.15%
$192.77
AMD
+1.20%
$219.03
ERIC
-0.84%
$8.17
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
CORZ
+3.72%
$19.21
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
C
+2.31%
$96.10
TSLA
-3.44%
$420.89
ETHD
+14.56%
$3.81
CJET
-3.52%
$0.12
ELAB
+83.43%
$9.55
GWAV
+113.04%
$18.13
CAN
-1.94%
$1.49
ATXS
+38.62%
$11.74
NAK
-4.93%
$2.52
NUAI
+39.14%
$3.27
WWR
+7.42%
$2.75
PLTD
-1.00%
$6.91
DVLT
+0.03%
$1.70
INTC
-5.72%
$35.08
EQX
+4.20%
$12.14
MSFT
+0.60%
$514.04
PLUG
-5.46%
$3.68
NEHC
-9.61%
$2.35
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRML
+27.79%
$29.75
CMG
+2.71%
$40.90
LYFT
+3.84%
$19.98
UUUU
-1.68%
$23.37
RGTZ
+7.66%
$10.01
FSM
+2.59%
$9.08
NIO
-3.18%
$6.95
LAES
+5.54%
$6.47
ATNF
0.00%
$1.98
CHR
-4.75%
$0.14
SOFI
-3.43%
$26.20
WIT
+1.12%
$2.69
STAI
-15.20%
$0.53
NXE
+2.51%
$8.98
IBRX
+5.08%
$2.48
WMT
+0.27%
$102.12
CRWV
-5.09%
$134.40
COIN
0.00%
$356.99
QCOM
+5.33%
$161.78
CIFR
-2.77%
$19.77
ADAP
-16.71%
$0.15
CTRA
+1.84%
$23.17
NEM
+5.00%
$89.40
ATYR
-8.88%
$0.96
QUBT
-3.63%
$20.67
LUMN
+2.58%
$6.75
NEO
+2.63%
$9.34
VHAI
+66.66%
$0.00
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
GWH
+117.54%
$9.05
IONZ
-32.55%
$2.29
GPUS
-10.39%
$0.43
SSKN
+42.92%
$2.20
F
+1.13%
$11.54
BURU
-16.87%
$0.42
AXDX
-61.36%
$0.03
ITP
+13.42%
$0.29
YYAI
-22.88%
$0.13
SOUN
+10.25%
$19.14
RR
+8.95%
$6.45
MP
+21.34%
$95.06
USAR
+18.61%
$38.68
IONQ
+16.19%
$82.09
BITF
-4.45%
$5.15
UAMY
+36.85%
$16.71
ABAT
+36.59%
$9.22
KDLY
-1.56%
$0.85
RGTI
-4.27%
$52.55
NVTS
+16.85%
$11.65
EOSE
+23.37%
$17.05
UGRO
+34.02%
$0.49
EDHL
+74.38%
$0.87
RMBL
+60.50%
$3.21
BULL
+2.98%
$11.74
ADD
-25.47%
$0.05
XCH
+103.41%
$1.68
CLSK
+3.94%
$20.04
SRM
+53.27%
$10.30
MNTS
+17.83%
$1.68
GDXD
-13.62%
$0.73
SMR
+14.72%
$45.02
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
SLB
+1.73%
$32.27
WLGS
-5.57%
$0.04
BYND
-16.89%
$0.86
ETWO
0.00%
$3.30
AFMD
-34.94%
$0.18
IXHL
+4.29%
$0.40
TMQ
+16.92%
$7.67
NVDA
-4.29%
$180.22
MU
+6.15%
$192.77
AMD
+1.20%
$219.03
ERIC
-0.84%
$8.17
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
CORZ
+3.72%
$19.21
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
C
+2.31%
$96.10
TSLA
-3.44%
$420.89
ETHD
+14.56%
$3.81
CJET
-3.52%
$0.12
ELAB
+83.43%
$9.55
GWAV
+113.04%
$18.13
CAN
-1.94%
$1.49
ATXS
+38.62%
$11.74
NAK
-4.93%
$2.52
NUAI
+39.14%
$3.27
WWR
+7.42%
$2.75
PLTD
-1.00%
$6.91
DVLT
+0.03%
$1.70
INTC
-5.72%
$35.08
EQX
+4.20%
$12.14
MSFT
+0.60%
$514.04
PLUG
-5.46%
$3.68
NEHC
-9.61%
$2.35
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
CRML
+27.79%
$29.75
CMG
+2.71%
$40.90
LYFT
+3.84%
$19.98
UUUU
-1.68%
$23.37
RGTZ
+7.66%
$10.01
FSM
+2.59%
$9.08
NIO
-3.18%
$6.95
LAES
+5.54%
$6.47
ATNF
0.00%
$1.98
CHR
-4.75%
$0.14
SOFI
-3.43%
$26.20
WIT
+1.12%
$2.69
STAI
-15.20%
$0.53
NXE
+2.51%
$8.98
IBRX
+5.08%
$2.48
WMT
+0.27%
$102.12
CRWV
-5.09%
$134.40
COIN
0.00%
$356.99
QCOM
+5.33%
$161.78
CIFR
-2.77%
$19.77
ADAP
-16.71%
$0.15
CTRA
+1.84%
$23.17
NEM
+5.00%
$89.40
ATYR
-8.88%
$0.96
QUBT
-3.63%
$20.67
LUMN
+2.58%
$6.75
NEO
+2.63%
$9.34
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.